293 related articles for article (PubMed ID: 29458045)
1. Aldose reductase inhibitor, fidarestat prevents doxorubicin-induced endothelial cell death and dysfunction.
Sonowal H; Pal P; Shukla K; Saxena A; Srivastava SK; Ramana KV
Biochem Pharmacol; 2018 Apr; 150():181-190. PubMed ID: 29458045
[TBL] [Abstract][Full Text] [Related]
2. Aldose reductase regulates hyperglycemia-induced HUVEC death via SIRT1/AMPK-α1/mTOR pathway.
Pal PB; Sonowal H; Shukla K; Srivastava SK; Ramana KV
J Mol Endocrinol; 2019 Jul; 63(1):11-25. PubMed ID: 30986766
[TBL] [Abstract][Full Text] [Related]
3. Aldose reductase regulates doxorubicin-induced immune and inflammatory responses by activating mitochondrial biogenesis.
Sonowal H; Saxena A; Qiu S; Srivastava S; Ramana KV
Eur J Pharmacol; 2021 Mar; 895():173884. PubMed ID: 33482179
[TBL] [Abstract][Full Text] [Related]
4. Aldose reductase inhibitor increases doxorubicin-sensitivity of colon cancer cells and decreases cardiotoxicity.
Sonowal H; Pal PB; Wen JJ; Awasthi S; Ramana KV; Srivastava SK
Sci Rep; 2017 Jun; 7(1):3182. PubMed ID: 28600556
[TBL] [Abstract][Full Text] [Related]
5. Aldose reductase inhibitor, fidarestat regulates mitochondrial biogenesis via Nrf2/HO-1/AMPK pathway in colon cancer cells.
Shukla K; Sonowal H; Saxena A; Ramana KV; Srivastava SK
Cancer Lett; 2017 Dec; 411():57-63. PubMed ID: 28986187
[TBL] [Abstract][Full Text] [Related]
6. Aldose reductase inhibition suppresses azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice.
Saxena A; Shoeb M; Tammali R; Ramana KV; Srivastava SK
Cancer Lett; 2014 Dec; 355(1):141-7. PubMed ID: 25218594
[TBL] [Abstract][Full Text] [Related]
7. Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats.
Obrosova IG; Minchenko AG; Vasupuram R; White L; Abatan OI; Kumagai AK; Frank RN; Stevens MJ
Diabetes; 2003 Mar; 52(3):864-71. PubMed ID: 12606532
[TBL] [Abstract][Full Text] [Related]
8. Aldose Reductase Inhibitor, Fidarestat Prevents High-fat Diet-induced Intestinal Polyps in Apc
Saxena A; Tammali R; Ramana KV; Srivastava SK
Curr Cancer Drug Targets; 2018; 18(9):905-911. PubMed ID: 28786349
[TBL] [Abstract][Full Text] [Related]
9. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.
Obrosova IG; Pacher P; Szabó C; Zsengeller Z; Hirooka H; Stevens MJ; Yorek MA
Diabetes; 2005 Jan; 54(1):234-42. PubMed ID: 15616034
[TBL] [Abstract][Full Text] [Related]
10. Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis.
Drel VR; Pacher P; Ali TK; Shin J; Julius U; El-Remessy AB; Obrosova IG
Int J Mol Med; 2008 Jun; 21(6):667-76. PubMed ID: 18506358
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the aldose reductase inhibitor fidarestat on ischemia-reperfusion injury in rat retina.
Obrosova IG; Maksimchyk Y; Pacher P; Agardh E; Smith ML; El-Remessy AB; Agardh CD
Int J Mol Med; 2010 Jul; 26(1):135-42. PubMed ID: 20514433
[TBL] [Abstract][Full Text] [Related]
12. A Chemosensitizer Drug: Disulfiram Prevents Doxorubicin-Induced Cardiac Dysfunction and Oxidative Stress in Rats.
Sonawane VK; Mahajan UB; Shinde SD; Chatterjee S; Chaudhari SS; Bhangale HA; Ojha S; Goyal SN; Kundu CN; Patil CR
Cardiovasc Toxicol; 2018 Oct; 18(5):459-470. PubMed ID: 29779119
[TBL] [Abstract][Full Text] [Related]
13. Docosahexaenoic Acid Attenuates Doxorubicin-induced Cytotoxicity and Inflammation by Suppressing NF-κB/iNOS/NO Signaling Pathway Activation in H9C2 Cardiac Cells.
Wang ZQ; Chen MT; Zhang R; Zhang Y; Li W; Li YG
J Cardiovasc Pharmacol; 2016 Apr; 67(4):283-9. PubMed ID: 26657886
[TBL] [Abstract][Full Text] [Related]
14. Prevention of VEGF-induced growth and tube formation in human retinal endothelial cells by aldose reductase inhibition.
Yadav UC; Srivastava SK; Ramana KV
J Diabetes Complications; 2012; 26(5):369-77. PubMed ID: 22658411
[TBL] [Abstract][Full Text] [Related]
15. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy.
Zhang QL; Yang JJ; Zhang HS
Biomed Pharmacother; 2019 Jan; 109():71-83. PubMed ID: 30396094
[TBL] [Abstract][Full Text] [Related]
16. Prevention of doxorubicin (DOX)-induced genotoxicity and cardiotoxicity: Effect of plant derived small molecule indole-3-carbinol (I3C) on oxidative stress and inflammation.
Hajra S; Patra AR; Basu A; Bhattacharya S
Biomed Pharmacother; 2018 May; 101():228-243. PubMed ID: 29494960
[TBL] [Abstract][Full Text] [Related]
17. Didymin prevents hyperglycemia-induced human umbilical endothelial cells dysfunction and death.
Shukla K; Sonowal H; Saxena A; Ramana KV
Biochem Pharmacol; 2018 Jun; 152():1-10. PubMed ID: 29548811
[TBL] [Abstract][Full Text] [Related]
18. Aldose reductase inhibition suppresses colon cancer cell viability by modulating microRNA-21 mediated programmed cell death 4 (PDCD4) expression.
Saxena A; Shoeb M; Ramana KV; Srivastava SK
Eur J Cancer; 2013 Oct; 49(15):3311-9. PubMed ID: 23827854
[TBL] [Abstract][Full Text] [Related]
19. Pyrroloquinoline quinine ameliorates doxorubicin-induced autophagy-dependent apoptosis via lysosomal-mitochondrial axis in vascular endothelial cells.
Jiang C; Jiang L; Li Q; Liu X; Zhang T; Yang G; Zhang C; Wang N; Sun X; Jiang L
Toxicology; 2019 Sep; 425():152238. PubMed ID: 31226464
[TBL] [Abstract][Full Text] [Related]
20. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo.
Hattori T; Matsubara A; Taniguchi K; Ogura Y
Curr Eye Res; 2010 Feb; 35(2):146-54. PubMed ID: 20136425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
